2011 annual financial data

Regeneron Pharmaceuticals 2011 Financial results

Regeneron Pharmaceuticals 2011 financial results with verified reported values.

Direct answer

Revenue was 445,824,000 USD.

Operating income was -205,159,000 USD and net income was -221,760,000 USD.
Operating cash flow was -141,682,000 USD.

Get free Regeneron Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
445,824,000 USD
Operating income
-205,159,000 USD
Net income
-221,760,000 USD
Operating cash flow
-141,682,000 USD